Information For Authors
- Manuscript Submission Guidelines
- Author Benefits Program
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
Submitting Your Manuscript
The Journal of Neurotrauma publishes articles dealing with all aspects of neurotrauma. This includes the anatomy, biochemistry, biophysics, immunology, pathology, pharmacology, and physiology of brain, spinal, and nerve injury. Articles published in this journal emphasize morphological, physiological, and biochemical studies of injured neurons and glial cells, mechanisms and treatments of acute and chronic injury of the nervous system, neural and glial regeneration, transplantation, in vivo and in vitro injury models, cellular growth factors, blood flow, and metabolism of injured nervous tissues, and recovery of function. Both laboratory and clinical studies are encouraged. The Journal will consider original research articles, reviews, short communications, and letters to the editor. Case reports are not accepted by the Journal.
Journal of Neurotrauma carries a manuscript submission fee* of $75.00 USD upon submission of each new manuscript. Upon payment, you will be provided with a Manuscript Submission Code, and will be prompted to enter this information when uploading your files to our peer-review system. Please note: Securing a token does not automatically create an account in our peer-review system. If you do not already have an account, you will be asked to create one before you can begin your submission. Submissions do not need to be completed at once. Submitting authors/agents may begin the submission process, save their work, and return to the site to complete the upload(s) at a later time. There is no limit on the number of times one can save their work and subsequently resume the submission. Doing so will not incur additional charges.
Authors whose submissions do not comply with the Instructions for Authors will have their manuscripts un-submitted so that the file(s) may be adjusted accordingly. Directions regarding the necessary corrective actions will be provided in an email to the corresponding author at the time that the manuscript is un-submitted. The submitting author/agent will then be provided with the opportunity to re-upload the corrected file(s). If a manuscript is un-submitted, it will reside in the corresponding author’s “Author Center” as a draft, and the submitting author/agent will be able to make the necessary adjustments and re-upload the manuscript without incurring another manuscript processing charge.
*The manuscript submission fee is independent of the editorial decision and is non-refundable.
The submitting author is required to complete the submission using an ORCID identifier. Please visit the ORCID website for more information, or to register. You must have an account in ScholarOne for Journal of Neurotrauma before logging in with an ORCID identifier.
Manuscript Submission Site
Create an Account in ScholarOne
If you do not already have an account in ScholarOne for Journal of Neurotrauma, you will need to create one. Once you create your account, you may log in to the system to begin your submission. Each listed author on a submission must either have an account, or have one created, in the submission system.
Check the Journal’s PEER REVIEW POLICIES
For technical information on using ScholarOne, contact AuthorServices@liebertpub.com
All authors, including the co-authors, should be responsible for a significant part of the manuscript. All authors and co-authors should have taken part in writing the manuscript, reviewing it, and revising its intellectual and technical content. Any author whose name appears on a manuscript assumes responsibility and accountability for the results.
Please note that if manuscripts are submitted by third parties (i.e., editing services or other agents), those third parties must submit the manuscript as a submitting agent, using a corporate or official email account. In addition, the name and company of the submitting agent must be disclosed in the cover letter. Author are responsible for manuscripts submitted by third parties. If we determine that a non-disclosed third party submitted the manuscript without following these procedures, we reserve the right to immediately reject the manuscript.
All Original submissions must contain:
- An Institutional Review Board (IRB) approval (or waiver) statement in the Methods section
- Acknowledgments section (if applicable) after the Conclusion of the paper, followed by
- An Author Contribution statement for each listed author, followed by
- An Author Disclosure Statement for each author listed on a submission, even if there are no conflicts to disclose, followed by,
- Funding statement(s), even if there is no funding information to declare.
All manuscripts must be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals. www.icmje.org
Manuscripts submitted to Journal of Neurotrauma that report on studies of preclinical testing of purported acute stroke therapies should adhere to the updated Stroke Therapy Academic Industry Roundtable (STAIR) Preclinical Recommendations. Please refer to: Fisher M, Feuerstein G, Howells DW, et al. Update of the Stroke Therapy Academic Industry Roundtable preclinical recommendations. Stroke 2009;40:2244–2250. (https://pubmed.ncbi.nlm.nih.gov/19246690/)
When submitting your manuscript for peer review, be prepared to:
- Enter the full title of the manuscript
- Enter the full names and institutional affiliations of ALL listed authors
- Enter ALL listed authors' institutional email addresses
- Identify the corresponding author
- Enter a running (abbreviated) title of no more than 45 characters (including spaces).
- Enter 3–6 keywords or phrases.
- Provide an unstructured abstract of no more than 250 words, which presents the reasons for the study, the main findings (with specific data), and the principal conclusions.
- Provide the names and email addresses of at least five potential preferred reviewers familiar with the field. Please make sure preferred reviewers are not from your university or institution or with whom you have collaborated. Anyone whom the author does not want to be considered should also be named as a non-preferred reviewer. Ultimate reviewer selection is at the Editor’s discretion.
- Confirm that the material has not been published or submitted for publication elsewhere.
Create an Effective Title
- Manuscript titles should be brief, contain key terms, and clearly identify the purpose of the work conducted
- Manuscript titles should not exceed 15 -18 words. Exceptions can be made with the Editor’s approval
- Manuscript titles should be direct and to the point. Remember that the journal has a global readership, so clear and concise non-vernacular language is most effective
- Avoid the use of specific locations in the title
- Do not use proprietary/trademarked names in the title
- Do not use acronyms in the title unless they are universally recognized and accepted
- NOTE: The title page of your submission must be included as part of your main text document (not as a separate file).
All file names should be in English and contain only alphanumeric characters. Do not include spaces, symbols, special characters, dashes, dots, or underscores. Label each file with the first author's last name, followed by the content of the file (i.e.: SmithText; SmithTables; SmithFigureLegends; SmithFig1, etc.)
Important: Please upload individual files of all manuscript material as described herein — please do NOT upload a combined PDF file containing all material in your submission.
Preparation of Manuscript
Prepare text of manuscripts, figure legends, and tables in Microsoft Word, double spaced. The order of elements in each manuscript should be:
- Title page (with full manuscript title, all contributing authors’ names, highest academic degrees, institutional titles, and institutional affiliations, a short running title, a denotation of the corresponding author, and a list of 3-6 keywords). We require the full mailing address and contact information (telephone, fax, and e-mail address) for EACH author listed on your article. Please also include the address(es).
- Main text (do not embed figures or tables)
- Conclusion (if applicable; as a separate paragraph, not as part of the Discussion section)
- Acknowledgments (if applicable)
- Authorship confirmation statement (see below)
- Author(s’) disclosure statement(s) (see below)
- Funding statement (see below)
- Figure legends
- Supplemental files (if applicable; Supplemental Information will not be posted as part of the Instant Online version of the manuscript)
Maximum word count for original articles should not exceed 3,000 words. In general, the text should be organized under the headings: Introduction, Materials and Methods, Results, and Discussion. Begin each section on a separate page. One subsection level is allowed. Use only standard abbreviations, which can be found in the AMA’s Manual of Style for Authors & Editors or the Council of Biology Editors Style Manual, 10/e. At first usage, spell out terms and provide abbreviations in parentheses. Thereafter, use only the abbreviations. It is not necessary to spell out standard units of measure. Use generic names for drugs if possible. If you wish to use a proprietary drug name the first time it appears, use the generic name followed by the proprietary name, manufacturer, and location in parentheses.
References must be prepared in Word, double spaced, and numbered consecutively as they are cited in the text (using superscript numbers). Include the reference section as part of the main text file, not as a separate file. References appearing for the first time in tables and figures must be numbered in sequence with those cited in the text where the table or figure is mentioned. Use journal abbreviations as provided by PubMed/Medline. List all authors when there are six or fewer. When there are more than six authors, list the first three, followed by et al. For book citations, volume and edition numbers should be included when appropriate. All references in the text should be included in the reference list, and all references in the reference list should have a corresponding citation in the main text of the manuscript.
If references to personal communications, unpublished data, or manuscripts “in preparation” or “submitted for publication” are used, they are not to be in the list of references. They should be referred to in the text in parentheses: (AB Jones, personal communication, month and year). Include among the references any articles that have been accepted but have not yet published; identify the name of publication and add "In Press." If the reference has been published online, provide the DOI number in place of the page range. References to abstracts should be indicated as such, with the abstract number included, if applicable.
Sample style for references:
Volovici V, Steyerberg EW, Cnossen MC, et al. Evolution of evidence and guideline recommendations for the medical management of severe traumatic brain injury. J Neurotrauma 2019;36:3183-3189.
Jallo J, Loftus C, eds. Neurotrauma and Critical Care of the Brain, 2nd ed. New York, NY: Thieme Medical Publishers, Inc.; 2018.
Chapter in a book:
Tran H, Krasberg M, Nemoto EM, Yonas H. Noninvasive neuromonitoring in severe traumatic brain injury. In: Jallo J, Loftus C, eds. Neurotrauma and Critical Care of the Brain, 2nd ed. New York, NY: Thieme Medical Publishers, Inc.; 2018, pp. 60-67.
Figure legends should be uploaded as a separate Word file and double spaced. In the legend, provide explanations for any abbreviations, arrows, etc. that appear in the figure. If the illustration is taken from a copyrighted publication, permission must be secured, appropriate credit must be given in the legend, and a corresponding reference must appear in the reference section.
All tables should be prepared in one single Word file. Provide a title for each table. Cite tables in sequence in the text. Explain abbreviations used in the body of the table in footnotes. Tabular data should not be duplicated in figures. If the table is taken from a copyrighted publication, permission must be secured, appropriate credit must be given in the legend, and a corresponding reference must appear in the reference section.
- Submission of high resolution .TIFF or .EPS figure files is strongly recommended.
- The top of the illustration should be indicated.
- Figures should not be embedded within the manuscript file.
- Cite figures consecutively in text within parentheses.
- A legend should be supplied for each figure and all legends numbered consecutively.
- Images should not show the name of a patient or a manufacturer.
- Do not include any illustrations as part of your text file.
Photomicrographs should be cropped to 8cm width. Electron photomicrographs should have internal scale markers. If a figure consists of two or more parts, individual parts should have similar dimensions.
Materials taken from other sources must be accompanied by a written statement from both author and publisher giving permission to the journal for reproduction. If clearances are required by the author’s institution, statements concerning such clearance should be provided in the manuscript.
Following the references, provide the name and complete affiliation and institutional email address of the person to whom correspondence should be sent.
Processing charges and submission codes are NOT required for revisions to previously submitted manuscripts. To upload a revision of a manuscript, the submitting author should log in to their Author Center and click on “Revised Manuscripts in Draft.” The manuscript will appear in this area, and the submitting author will be able to upload revised files without paying any charges or entering a submission code. All revised submissions will be required to meet all formatting conditions described herein. Submissions that do not satisfy these requirements will be un-submitted and returned to the submitting author for proper configuration.
Letters to the Editor
Journal of Neurotrauma will consider Letters to the Editor commenting on the scientific content of an article published in the Journal. Letters should not exceed 500 words of text and 5 references. Letters submitted for publication must be original and must not be submitted to any other publication simultaneously.
Journal Policies on:
Licensing Information: OPEN ACCESS and Copyright
Data Sharing and Preprint Policies
Post-Acceptance and Post-Publication Policies
Correction Statements / Retractions
Reprints, Permissions, & Social Media Use
Plagiarism Detection Software
Definitions of Scientific Misconduct
Responding to Allegations of Scientific Misconduct
Press Embargo Policy
Archiving and Preservation
For questions regarding manuscript submissions, contact our Author Services Division.
Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option
Does your research funder have an open access mandate or would you like to expand the dissemination of your research?
The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.
The benefits of Liebert Open Access include:
- High visibility; open access articles are freely available online upon publication
- You retain copyright with the open access license allowing broad dissemination of your research
- You can freely share your article in repositories and research networks without restrictions
- Easy compliance with open access mandates
- Rigorous editorial and peer-review
- Targeted email announcement featuring a direct link to article
Identification and Marketing
Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.
Copyright and Licensing
If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
Ordering Open Access
Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email firstname.lastname@example.org.
Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form. You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.
Publishing biomedical or biotechnology research?
Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.
*Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.
Browse journals in the Liebert Open Access portfolio:
NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.
Publishing in Subscription Journals
By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.
Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.
The final published article (version of record) can never be archived in a repository, preprint server, or research network.
Publishing Open Access
Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email email@example.com or visit Liebert Open Access for more information.